Lind Global Fund II LP 13D and 13G filings for PaxMedica, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:10 pm Sale |
2024-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 985,000 9.900% |
-23,599 (-2.34%) |
Filing |
| 2024-11-14 7:22 pm Purchase |
2024-09-30 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 1,008,599 8.800% |
756,829 (+300.60%) |
Filing |
| 2024-02-13 8:11 pm Purchase |
2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 251,770 9.900% |
251,770 (New Position) |
Filing |